#North American patient examination devices market

[businessmarketreports]

An Overview of North America Patient Examination Devices Market: Trends and Insights

The North American patient examination devices market is a dynamic and rapidly evolving sector, driven by increasing healthcare expenditure, technological advancements, and a growing aging population.

Key Trends Shaping the Market:

Technological Advancements:

Digital Imaging: The increasing adoption of digital imaging technologies, such as digital X-ray and ultrasound, is improving diagnostic accuracy and efficiency.

Telehealth and Remote Monitoring: The integration of telehealth and remote monitoring technologies is enabling remote patient assessment and diagnosis.

AI and Machine Learning: The application of AI and machine learning algorithms is enhancing the accuracy and speed of medical diagnosis.

Aging Population: The aging population in North America is associated with a higher prevalence of chronic diseases, leading to increased demand for patient examination devices.

Rising Healthcare Expenditure: Increased healthcare spending is enabling greater access to advanced medical devices and technologies.

Focus on Patient-Centered Care: The emphasis on patient-centered care is driving the development of patient-friendly and user-friendly examination devices.

Major Product Segments:

Diagnostic Imaging Equipment: Includes X-ray machines, ultrasound systems, CT scanners, and MRI machines.

Ophthalmic Devices: Used for eye examinations, including ophthalmoscopes and slit lamps.

Otoscopes: Used for ear examinations.

Vital Signs Monitoring Devices: Used to measure blood pressure, heart rate, and other vital signs.

Challenges and Opportunities:

Regulatory Hurdles: Navigating the complex regulatory landscape for medical devices in North America can be challenging.

Reimbursement Challenges: Obtaining adequate reimbursement for advanced medical devices can be difficult, particularly in a cost-conscious healthcare environment.

Supply Chain Disruptions: Global supply chain disruptions can impact the availability and cost of medical devices.

Emerging Technologies: The development of innovative medical devices, such as wearable health monitors and point-of-care diagnostic devices, presents significant opportunities for the market.

Conclusion

The North American patient examination devices market is a dynamic and growing sector. By addressing challenges such as regulatory hurdles, reimbursement issues, and supply chain disruptions, the market can continue to expand and improve patient care.

[snehalblog]

Innovations in Ultrasound and Electrosurgical Energy Dissectors Market: Shaping the Future of Minimally Invasive Surgery - UnivDatos

According to a new report published by UnivDatos Markets Insights, the Ultrasound And Electrosurgical Energy Dissectors Market was valued at USD 9 Billion in 2022 & is expected to grow at a CAGR of 8% from 2023-2030. The analysis has been segmented into Type (Ultrasound Devices and Electrosurgical Devices); End User (Hospitals, Ambulatory Surgical Centers, and Others); Region/Country.

The Ultrasound And Electrosurgical Energy Dissectors market report has been aggregated by collecting informative data on various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the opioid market. The Ultrasound And Electrosurgical Energy Dissectors market report offers a detailed analysis of the latest industry developments and trending market factors influencing market growth. Furthermore, this statistical market research repository examines and estimates the Ultrasound And Electrosurgical Energy Dissectors market at the global and regional levels.

Request To Download Sample of This Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=51051&utm_source=LinkSJ&utm_medium=Snehal&utm_campaign=Snehal&utm_id=snehal

Key Market Dynamics

The increasing demand for minimally invasive surgeries is one of the key drivers of the ultrasound and electrosurgical energy dissectors market. Minimally invasive surgeries offer several advantages over traditional open surgeries, such as smaller incisions, reduced blood loss, shorter hospital stays, and quicker recovery times. As a result, there is a growing preference among both patients and healthcare professionals for these less invasive procedures. The increasing adoption of minimally invasive surgeries across a wide range of medical specialties is driving the demand for ultrasound and electrosurgical energy dissectors. For instance, as per the American Society of Plastic Surgeons, about 23.67 Million Minimally-Invasive procedures were performed in America during the year 2022. These procedures are now being used in various fields, including gynecology, urology, general surgery, orthopedics, and cardiovascular surgery. The versatility of these devices and their ability to enhance surgical precision and patient outcomes are contributing to their growing popularity.

Ultrasound And Electrosurgical Energy Dissectors Market Geographical Segmentation Includes:

·         North America (U.S., Canada, and the Rest of North America)

·         Europe (Germany, UK, Spain, Italy, France, Rest of Europe)

·         Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific)

·         Rest of the World

Asia-Pacific is expected to witness fast growth in the Ultrasound And Electrosurgical Energy Dissectors market. This is mainly due to the cost-effectiveness of the Ultrasound And Electrosurgical Energy Dissectors and the presence of the countries with emerging economies in the region.

Competitive Landscape

The degree of competition among prominent global companies has been elaborated by analyzing several leading key players operating worldwide. The specialist team of research analysts sheds light on various traits such as global market competition, market share, most recent industry advancements, innovative product launches, partnerships, mergers, or acquisitions by leading companies in the opioid market. The major players have been analyzed by using research methodologies such as Porter’s Five Forces Analysis for getting insight views on global competition.

Ask for Report Customization - https://univdatos.com/get-a-free-sample-form-php/?product_id=51051&utm_source=LinkSJ&utm_medium=Snehal&utm_campaign=Snehal&utm_id=snehal

Key questions resolved through this analytical market research report include:

• What are the latest trends, new patterns, and technological advancements in the opioid market?

• Which factors are influencing the Ultrasound And Electrosurgical Energy Dissectors market over the forecast period?

• What are the global challenges, threats, and risks of the opioid market?

• Which factors are propelling and restraining the opioid market?

• What are the demanding global regions of the opioid market?

• What will be the global market size in the upcoming years?

• What are the crucial market acquisition strategies and policies applied by global companies?

• What are the descriptive profiles of key companies along with their SWOT analysis?

We understand the requirement of different businesses, regions, and countries, we offer customized reports as per your requirements of business nature and geography. Please let us know If you have any custom needs.

[amrutatbrc1]

Eye Testing Equipment Market : Technology Advancements, Industry Insights, Trends And Forecast 2033

The Eye Testing Equipment Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Eye Testing Equipment Market: https://www.thebusinessresearchcompany.com/report/eye-testing-equipment-global-market-report

According to The Business Research Company’s Eye Testing Equipment Global Market Report 2024, The eye testing equipment market size is expected to see strong growth in the next few years. It will grow to $4.41 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to the increasing adoption of telemedicine, growing demand for portable and handheld devices, rising prevalence of diabetes and related eye disorders, increasing focus on preventive healthcare, and an expanding middle-class population. Major trends in the forecast period include the integration of AI and machine learning in diagnostics, the increasing use of virtual reality in eye examinations, the rise in demand for personalized eye care solutions, the development of advanced imaging technologies, and growing collaboration between tech companies and healthcare providers.

The increasing prevalence of eye-related disorders is expected to propel the growth of the eye-testing equipment market going forward. Eye-related disorders refer to a range of conditions affecting the eyes, including diseases such as glaucoma, cataracts, macular degeneration, and refractive errors such as myopia and hyperopia. The increase in the number of patients with eye-related disorders is due to factors such as aging populations, lifestyle changes, environmental factors, and lack in diagnostic capabilities leading to delay in problem detection. Eye testing equipment is used for early detection, accurate diagnosis, and effective monitoring of eye-related conditions such as glaucoma, cataracts, and macular degeneration. For instance, in January 2024, according to the Centers for Disease Control and Prevention, a US-based science and data-driven service organization that protects the public's health, over 3.4 million Americans aged 40 years and older were blind or visually impaired, which is expected to double by 2030. Therefore, the increasing prevalence of eye-related disorders will drive the growth of the eye-testing equipment market.

Get A Free Sample Of The Report (Includes Graphs And Tables): https://www.thebusinessresearchcompany.com/sample.aspx?id=17147&type=smp

The eye testing equipment market covered in this report is segmented –

1) By Device: Slit Lamp, Biometer, Perimeter, Tonometer, Optical Coherence Tomography (OCT), Fundus Camera, Autorefractor And Keratometer, Other Devices 2) By Application: General Examination, Glaucoma, Cataract, Other Applications 3) By End User: Hospital, Eye Clinic, Optometry Academic Institute

Major companies operating in the eye-testing equipment market are developing advanced eye-testing devices, such as handheld artificial intelligence fundus cameras, to enhance diagnostic accuracy and streamline screening processes. A handheld fundus camera enhanced with AI technology is used for capturing detailed images of the eye's fundus to assist in diagnosing eye conditions. For instance, in May 2024, Optomed USA, a US-based medical technology company, launched Optomed Aurora AEYE. It is a handheld AI-powered fundus camera specifically designed to quickly detect diabetic retinopathy beyond mild stages, enabling prompt eye screenings in primary care settings. This device simplifies the screening process with its user-friendly design, needing only one image per eye and delivering results within a minute.

The eye testing equipment market report table of contents includes:

1. Executive Summary 

2. Eye Testing Equipment Market Characteristics

3. Eye Testing Equipment Market Trends And Strategies

4. Eye Testing Equipment Market - Macro Economic Scenario

5. Global Eye Testing Equipment Market Size and Growth .............

32. Global Eye Testing Equipment Market Competitive Benchmarking

33. Global Eye Testing Equipment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Eye Testing Equipment Market

35. Eye Testing Equipment Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[market-spy]

Telemedicine Market to Reach USD 430.72 Billion by 2031, Growing at 17.95% CAGR | SkyQuest Technology

SkyQuest projects that the Telemedicine Market will attain a value of USD 430.72 billion by 2031, with a CAGR of 17.95% during the forecast period (2024-2031). The telemedicine market has been growing tremendously at an exponential rate because of the development of technology and the ever-growing demand for healthcare. It is mainly designed to enable access to health care services, increase the effectiveness of service provision, and improve the quality-of-service deliveries by mitigating the limitations created by geographic location, without necessarily overloading traditional health care facilities or increasing costs. The social distancing measures that were crafted due to the COVID-19 pandemic forced the adoption of telemedicine, which was further enhanced by grants and funding from the governments.

Download a Detailed Overview: https://www.skyquestt.com/sample-request/telemedicine-market

Browse in-depth TOC on "Telemedicine Market"

Pages – 165

Tables - 118

Figures – 77

Healthcare Providers Leads the Market as Telemedicine Offers Easy and Hassle-Free Checkups Healthcare providers are the barons controlling the major market share. With telemedicine, doctors and other healthcare workers can extend consultations without physically contacting the patients at the same time, patients can be remotely supervised in real-time without any hassle and waiting time. Telemedicine is used in this segment owing to its effectiveness and convenience that influences the expansion of the telemedicine market.

Healthcare Consumers Stands as the Rapidly Growing Segment Owing to Virtual Consultation

The healthcare consumers segment is the most rapidly evolving segment of the telemedicine market. The growing use of such devices like smartphones and the internet, as well as awareness of the advantages of telehealth services, including increasing chronic diseases has made routine monitoring for the patient mandatory. This has led to the growth of this industry. Healthcare consumers show more readiness to depend on virtual consulting, which defines this segment as the major source of potential growth in the future.

North America Continues to be the Leading Consumer with High Telemedicine Adoption Rate

North America is the dominating region in this market, largely due to its advanced healthcare infrastructure, high adoption rate of telemedicine technologies, and favorable government initiatives. The region also houses major telemedicine service providers and huge research and development activities, high investment and high prevalence of chronic diseases demanding continuous medical attention make the US play an important role in driving the market.

Telemedicine Market Insights:

Drivers

Increasing Prevalence of Chronic Diseases

Convenient and Timely Access to Medical Care in Remote Areas

Frequent Medical Consultations Needed by the Older Aging Population

Restraints

Limited Access to Digital Infrastructure

Lack of Physical Examination and Few Diagnostics Tests Done Remotely

Inconsistencies in Reimbursement Policies for Telemedicine

Prominent Players in Telemedicine Market

AMC Health

Siemens AG

General Electric Company

Teladoc Health Inc.

Medtronic plc

Koninklijke Philips N.V.

The Cigna Group

Oracle Corporation

American Well Corporation

MDLIVE, Inc.

Key Questions Answered in Telemedicine Market Report

At what CAGR Telemedicine Market is growing in the forecasted period?

Who are the leading Telemedicine providers in the market?

Where will the demand for the Telemedicine Market rapidly grow in the forecasted year?

This report provides the following insights:

Analysis of key drivers (growing demand for better data security, rising adoption of Blockchain and IoT technologies, increasing use of decentralized systems in different industry verticals), restraints (interoperability issues with legacy systems, complexities in integration with existing infrastructure, concerns regarding scalability of gas cleaning technologies systems), and opportunities (growing demand for data monetization, rising demand for transparent yet trusted transactions), influencing the growth of telemedicine market.

Market Penetration: All-inclusive analysis of product portfolio of different market players and status of new product launches.

Product Development/Innovation: Elaborate assessment of R&D activities, new product development, and upcoming trends of the telemedicine market.

Market Development: Detailed analysis of potential regions where the market has potential to grow.

Market Diversification: Comprehensive assessment of new product launches, recent developments, and emerging regional markets.

Competitive Landscape: Detailed analysis of growth strategies, revenue analysis, and product innovation by new and established market players.

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.

Contact:

Mr. Jagraj Singh

Skyquest Technology

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 351-333-4748

Email: sales@skyquestt.com

Visit Our Website: https://www.skyquestt.com/

[healthcaremarketanalysis]

Laboratory Information Management System (LIMS) Market Worth $3.8 billion by 2029

The size of global laboratory information management system market in terms of revenue was estimated to be worth $2.1 billion in 2024 and is poised to reach $3.8 billion by 2029, growing at a CAGR of 12.9% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

Download an Illustrative overview:

Browse in-depth TOC on "Laboratory Information Management System (LIMS) Market"

200 - Tables

40 - Figures

400 - Pages

Driver: Growing use of LIMS to comply with stringent regulatory requirements Automating routine lab procedures with the help of devoted workstations and software improves lab productivity and enables individual researchers to focus on important tasks. This is a major factor driving the adoption of informatics in the pharmaceutical and biotechnology industry. According to a study, error rates for fully automated operations vary from 1–5%, those for semi-automated operations range from 1–10%, while those for manual operations vary from 10–30% (Source: Journal of Lab Automation).

Restraint: High maintenance and service costs The high maintenance and service costs associated with LIMS solutions can significantly impact the growth of the LIMS market. While LIMS solutions offer numerous benefits in terms of streamlining laboratory workflows and improving data management, the costs involved in maintaining and servicing these systems can pose challenges for organizations, especially smaller laboratories or those with limited budgets.

Opportunity: Growing use of LIMS in cannabis industry

Medical cannabis has demonstrated effectiveness in a range of medical applications, including alleviating chemotherapy-induced nausea, stimulating appetite in AIDS patients, managing muscular spasms in multiple sclerosis patients, and reducing intraocular pressure in glaucoma patients. Due to these potential health benefits, numerous countries and states have legalized medical cannabis. This legalization has spurred the emergence of cannabis testing laboratories, which offer quality control services for the medical cannabis industry.

Challenge: Dearth of trained professionals With the growing trend towards digitization, the healthcare industry's adoption of IT solutions has surged significantly over the past decade. This has led to an increased demand for skilled IT professionals and individuals with advanced analytical capabilities to interpret data from CIT solutions, including LIMS. However, a substantial gap exists between the supply and demand for these skilled professionals, which may hinder the adoption of LIMS, especially in pharmaceutical, biotechnology, and medical device companies, which represent over 50% of the LIMS market.

North America dominated the laboratory information management system industry in 2023 The laboratory information management system market is segmented into five major regions- North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the Laboratory Information Management Systems (LIMS) market. This growth is propelled by factors such as the region's high per-capita healthcare expenditure, continuous innovation in laboratory technologies, and the integration of LIMS with Enterprise Resource Planning (ERP) and Clinical Decision Support (CDS) systems. The accessibility to advanced healthcare facilities and the increasing number of biobanks further contribute to the expanding LIMS market in North America. Additionally, the emphasis on quality control, regulatory compliance, and the adoption of digitization in laboratory processes are driving the demand for LIMS solutions in the region. Overall, the North American market's robust growth in the LIMS sector can be attributed to a combination of technological advancements, regulatory requirements, and the healthcare industry's evolving needs.

Prominent companies in this market include LabWare (US), LabVantage Solutions Inc. (US), Thermo Fisher Scientific Inc. (US), Agilent Technologies (US), LabLynx, Inc. (US), Dassault Systèmes (France), Labworks LLC (US), Autoscribe Informatics (a wholly owned subsidiary of Autoscribe Limited) (US), Accelerated Technology Laboratories (ATL) (US), CloudLIMS (US), Computing Solutions, Inc. (US), GenoLogics Inc. (an Illumina Company) (Canada), Siemens (Germany), Novatek International (Canada), Ovation (US), Clinsys (US), Eusoft Ltd. (Italy), Caliber International (US), LABTrack (US), Agilab SAS (US), Agaram Technologies (India), and AssayNet Inc. (Canada), Blaze Systems Corporation (US), and LabLogic Systems Limited (UK).

Recent Developments of the Laboratory Information Management Systems (LIMS) Industry:

In February 2024, Labware has inaugurated its newest office in Seoul, Korea and established LabWare Korea Co., Ltd. This office will provide localized support, training, and implementation services to LabWare's growing customer network in Korea. Staffed by experienced LIMS professionals, the office aims to strengthen LabWare's foothold in the Asia-Pacific region by offering tailored solutions to meet the unique needs of Korean organizations.

In January 2024, STARLIMS has launched Life Sciences for Public Health (LPH) 1.0, a LMS tailored for the Public Health sector. Featuring HTML5 browser-based technology, it signifies a significant advancement, promising a modernized user interface and enhanced functionalities. The release marks the beginning of a comprehensive, multi-year product roadmap aiming to elevate user experience and innovation in the Public Health LIMS market.

In Novemeber 2023, LabWare (US) partnered with Körber (US). This partnership was carried to seamlessly integrate capabilities between LabWare's Laboratory Information Management System (LIMS) and Körber's Manufacturing Execution System (MES) - PAS-X.

In October 2022, LabVantage Solutions, Inc. (US) and Biomax Informatics AG (Germany) finalized their merger agreement, with the goal of elevating scientific data contextualization, expediting product development, and delivering innovative capabilities for the life science and bio-manufacturing industries.

Content Source:

[shubhampawrainfinium]

"Ureteroscopes: Sustainable Market Growth or Just a Passing Trend in Urology?"

Introduction

Ureteroscopes are specialized endoscopic instruments used to examine and treat conditions within the ureter and bladder. They play a crucial role in urological procedures, allowing for the minimally invasive diagnosis and management of urological disorders such as kidney stones, tumors, and strictures. The market for ureteroscopes is expanding due to advancements in endoscopic technology, increasing incidence of urological conditions, and a growing preference for minimally invasive procedures. This report provides an overview of the ureteroscope market, including market dynamics, regional trends, segmentation, competitive landscape, and future outlook.

Market Dynamics

Drivers

Increasing Incidence of Urological Conditions: The rising prevalence of urological conditions such as kidney stones, bladder tumors, and urinary tract infections drives demand for ureteroscopes. Factors contributing to this rise include aging populations, lifestyle changes, and increased incidence of chronic conditions.

Technological Advancements: Innovations in ureteroscope technology, including improved imaging capabilities, flexible designs, and enhanced maneuverability, are driving market growth. Advances in miniaturization and high-definition imaging improve diagnostic accuracy and patient outcomes.

Preference for Minimally Invasive Procedures: There is a growing preference for minimally invasive procedures due to their benefits, including shorter recovery times, reduced postoperative pain, and lower risk of complications. Ureteroscopes enable such procedures, fueling market demand.

Challenges

High Costs: The cost of advanced ureteroscopes and associated disposable components can be high, which may limit access in cost-sensitive regions and impact adoption rates. High costs can also affect the overall affordability of urological procedures.

Technological Complexity: The advanced technology in ureteroscopes can lead to complexity in usage and maintenance. Training and expertise required to operate sophisticated devices can be a barrier to widespread adoption.

Regulatory and Reimbursement Issues: Navigating regulatory requirements and obtaining reimbursement for ureteroscopic procedures can be challenging. Variations in regulations and reimbursement policies across regions can affect market dynamics.

Opportunities

Emerging Markets: Expanding healthcare infrastructure and increasing healthcare spending in emerging markets, such as Asia-Pacific and Latin America, present significant growth opportunities for ureteroscope manufacturers.

Innovation and R&D: Continuous innovation in ureteroscope design, including improvements in flexibility, imaging, and ease of use, offers opportunities for market expansion. Companies investing in research and development can gain a competitive edge.

Growing Awareness and Training: Increasing awareness of urological health and improved training for healthcare professionals can drive demand for advanced ureteroscopic technologies. Educational initiatives and professional development programs can enhance market reach.

Sample Pages of  Report: https://www.infiniumglobalresearch.com/reports/sample-request/1660

Regional Analysis

North America: The North American market is a leader due to advanced healthcare systems, high prevalence of urological conditions, and significant investment in medical technology. The U.S. and Canada are key markets with high adoption rates of innovative ureteroscopes.

Europe: Europe features a mature market with strong demand driven by well-established healthcare infrastructure and a focus on minimally invasive procedures. Major markets include Germany, France, and the UK, where there is significant emphasis on technological advancements.

Asia-Pacific: The Asia-Pacific region is experiencing rapid growth due to expanding healthcare facilities, increasing prevalence of urological conditions, and rising healthcare investments. China, India, and Japan are prominent markets with substantial growth potential.

Latin America: Latin America shows growing demand for ureteroscopes as healthcare facilities improve and investments in medical technologies increase. Brazil and Mexico are leading markets with rising adoption of advanced urological technologies.

Middle East & Africa: The market in the Middle East and Africa is developing, with increasing healthcare investments and a focus on improving urological care. The region is expected to see growth as healthcare infrastructure expands and awareness of advanced technologies increases.

Market Segmentation

By Product Type:

Rigid Ureteroscopes

Flexible Ureteroscopes

Semi-Rigid Ureteroscopes

By Application:

Diagnosis

Treatment

By End User:

Hospitals

Urology Clinics

Ambulatory Surgical Centers

By Region:

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Competitive Landscape

Market Share of Large Players: Major companies such as Olympus Corporation, Karl Storz SE & Co. KG, and Boston Scientific Corporation hold significant market shares due to their extensive product portfolios and global reach.

Price Control: Large players have substantial influence over pricing due to their scale and market presence. However, competition and advancements in technology can affect pricing strategies.

Competition from Small and Mid-Size Companies: Smaller and mid-size companies challenge larger players by offering innovative or niche ureteroscopic solutions. These companies often focus on specific features or emerging technologies.

Key Players:

Olympus Corporation

Karl Storz SE & Co. KG

Boston Scientific Corporation

Stryker Corporation

Richard Wolf GmbH

Report Overview: https://www.infiniumglobalresearch.com/reports/global-ureteroscopes-market

Future Outlook

New Product Development: Continuous innovation in ureteroscope technology, such as enhanced imaging and flexible designs, is crucial for maintaining competitiveness and addressing evolving clinical needs.

Sustainability: The growing emphasis on sustainability in medical device manufacturing is shaping the market. Companies adopting eco-friendly materials and practices may appeal to environmentally conscious stakeholders and improve their market position.

Conclusion

The ureteroscope market is expanding due to increasing prevalence of urological conditions, technological advancements, and a preference for minimally invasive procedures. While challenges such as high costs and regulatory issues exist, opportunities in emerging markets and ongoing innovation offer significant growth potential. Companies focusing on new product development and sustainability will be well-positioned to succeed in this evolving market.

[credenceresearchdotblog]

The Colposcopes Market for colposcopes is projected to expand at a compound annual growth rate (CAGR) of 7.20%, from an estimated USD 745.2 million in 2023 to USD 1393.23 million in 2032.The global colposcopes market has been experiencing significant growth, driven by technological advancements, rising prevalence of cervical cancer, and increasing awareness about women's health. Colposcopes are essential diagnostic tools used primarily in gynecology for examining the cervix, vagina, and vulva. They provide magnified and illuminated views, enabling the detection of abnormal tissue that may indicate conditions such as cervical cancer or precancerous changes.

Browse the full report at https://www.credenceresearch.com/report/global-colposcopes-market

Market Overview

The colposcopes market can be segmented based on product type, modality, end-user, and region. The major product types include optical colposcopes and video colposcopes. Optical colposcopes use binoculars to provide a stereoscopic image, while video colposcopes are equipped with a camera and a display screen, offering enhanced visualization and documentation capabilities. In terms of modality, the market can be divided into portable, stationary, and handheld colposcopes. Key end-users include hospitals, diagnostic centers, and clinics.

Market Drivers

1. Rising Incidence of Cervical Cancer: Cervical cancer remains one of the most common cancers among women worldwide. The increasing prevalence of this disease has necessitated the use of advanced diagnostic tools like colposcopes for early detection and treatment. According to the World Health Organization (WHO), cervical cancer is the fourth most common cancer in women, with an estimated 570,000 new cases and 311,000 deaths in 2018.

2. Technological Advancements: Innovations in colposcope technology have significantly improved the accuracy and efficiency of cervical examinations. Modern colposcopes come with features such as high-definition imaging, digital documentation, and enhanced illumination, which aid in better diagnosis and patient outcomes.

3. Increasing Awareness and Screening Programs: Governments and healthcare organizations worldwide are actively promoting cervical cancer screening programs. Initiatives like the HPV vaccination and routine Pap smear tests have increased the demand for colposcopes. Awareness campaigns and educational programs have also played a crucial role in encouraging women to undergo regular check-ups.

4. Improving Healthcare Infrastructure: The expansion of healthcare facilities, especially in developing regions, has contributed to the growth of the colposcopes market. Improved access to healthcare services and the establishment of specialized diagnostic centers have facilitated the adoption of colposcopes.

Market Challenges

1. High Cost of Colposcopes: Advanced colposcopes with sophisticated features can be expensive, which may hinder their adoption, particularly in low-resource settings. The high cost of these devices can be a significant barrier for small clinics and diagnostic centers.

2. Lack of Skilled Professionals: The accurate interpretation of colposcopy results requires specialized training and expertise. A shortage of skilled professionals can limit the effective use of colposcopes, impacting the overall market growth.

Regional Analysis

1. North America: The North American colposcopes market is driven by a well-established healthcare system, high awareness levels, and robust screening programs. The United States, in particular, holds a significant market share due to the high prevalence of cervical cancer and the presence of key market players.

2. Europe: Europe is another prominent market for colposcopes, with countries like Germany, the UK, and France leading in terms of market share. The region's strong focus on women's health and early detection of cervical cancer has fueled market growth.

3. Asia-Pacific: The Asia-Pacific region is expected to witness the highest growth rate during the forecast period. Factors such as improving healthcare infrastructure, rising awareness about cervical cancer, and increasing government initiatives for screening programs are driving the market in this region. Countries like China and India are emerging as key markets due to their large population base and increasing healthcare expenditure.

4. Latin America and Middle East & Africa: These regions are gradually adopting colposcopes, driven by improving healthcare facilities and growing awareness. However, challenges such as limited access to advanced medical technologies and economic constraints still exist.

Competitive Landscape

The colposcopes market is highly competitive, with several key players focusing on product innovation and strategic partnerships to strengthen their market position. Major companies include Carl Zeiss Meditec AG, CooperSurgical, Inc., DYSIS Medical Ltd., Olympus Corporation, and Seiler Instrument Inc. These companies are investing in research and development to introduce advanced colposcopes with improved features.

Key Players

Cooper Surgical, Inc. (US)

Carl Zeiss AG (Germany)

Olympus Corporation (Japan)

Koninklijke Philips N.V. (Netherlands)

Edan Instruments, Inc. (China)

Kernel Medical Equipment Co., Ltd. (China)

MedGyn Products, Inc. (US)

ATMOS MedizinTechnik GmbH & Co. KG (Germany)

BOVIE MEDICAL (US)

DYSIS Medical Inc. (US)

Others

Segmentation

By Type of Colposcope

Optical Colposcopes

Digital Colposcopes

Video Colposcopes

Portable/Hanheld Colposcopes

By Magnification Levels

Low Magnification Colposcopes

Medium Magnification Colposcopes

High Magnification Colposcopes

By Illumination Technology

Halogen Illumination

LED Illumination

Xenon Illumination

By Application

Cervical Cancer Screening

Biopsy Guidance

Treatment Monitoring

Research and Education

By End User

Hospitals and Clinics

Diagnostic Centers

Ambulatory Surgical Centers (ASCs)

Research Institutes and Universities

Mobile Clinics and Outreach Programs

By Region

North America

U.S

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

The Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/global-colposcopes-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[uptothetrendblogs]

Polymer-Based Prefilled Syringe Market

Polymer-Based Prefilled Syringe Market Seen Soaring 4.9% Growth And Valued At USD 2.87 Billion By 2023, Projects Univdatos Market Insights

Key Highlights of the Report:

Rapid Market Growth: The report focuses on the rapid growth of the polymer-based prefilled syringes market in North America. This growth is being driven by factors like a rising demand for advanced medical devices, a rising prevalence of chronic diseases, and an increasing focus on patient safety and convenience.

Superior Safety and Usability: Polymer-based prefilled syringes outperform conventional glass syringes when it comes to both safety and usability. Patient satisfaction and improved medication administration practices are helped along by features like increased durability, breakage resistance, and user-friendly design elements.

Compatibility and Stability: The report emphasizes that polymer-based prefilled syringes are compatible and stable, making them suitable for a wide range of medications, including biologics and specialty medications.

Regulatory Compliance: One of the most crucial factors in the adoption of polymer-based prefilled syringes is regulatory compliance. The report examines the thorough testing and approval processes expected to guarantee consistency with administrative guidelines set out by specialists like the FDA in the US and Wellbeing Canada.

Future Prospects and Innovations: The report provides insights into the polymer-based prefilled syringes market's prospects and innovations, including ongoing R&D efforts aimed at improving performance and functionality.

According to a new report by UnivDatos Market Insights, the Polymer-Based Prefilled Syringe Market is expected to reach USD 2.87 Billion in 2023 by growing at a CAGR of ~4.9%. The population is ageing globally and with this comes the increased incidence of chronic conditions that need medications frequently. Prefilled syringes offer convenience and ease of use for self-administration or by caregivers, driving their adoption. As per the United Nations World Population Ageing 2023 report, there are now over 10 million older people in the nation, placing a significant financial strain on the social security and healthcare systems. Even though the proportion of older people was just 4.9% in 2023.

Unlock The Insights of This Strategic Report- https://univdatos.com/report/polymer-based-prefilled-syringe-market/get-a-free-sample-form.php?product_id=61521

As demand for prefilled syringes rises, other pharma and biotech businesses around the globe are expected to transition from traditional syringes and other packaging systems to polymer-based prefilled syringes for their injectable products, which will drive the market deeper into penetration. Furthermore, firms that are involved in the research and development of advanced polymers for various applications or those firms that design new and unique polymers will have the upper hand in the market. For example, on March 18, 2024, SCHOTT Pharma will be establishing a new prefilled syringe manufacturing plant in Wilson, North Carolina, for a total of USD 371 million, with over 400 planned employees, to meet the demand for glass and polymer prefilled syringes for mRNA, GLP-1, and other therapeutic applications in the United States.

The ability to tailor treatments to individual needs and desired outcomes enhances patient satisfaction and drives market demand. Some of the most performed Polymer-Based Prefilled Syringe include:

·         On March 18, 2024, SCHOTT Pharma invests USD 371 million in a new prefilled syringe manufacturing facility in Wilson, North Carolina, creating over 400 jobs, aiming to meet the demand for glass and polymer prefilled syringes for mRNA, GLP-1, and other therapies in the U.S.

.

According to the report, the impact of polymer-based prefilled syringe resources has been identified to be high for the North American area. Some of how this impact has been felt include:

Asia-Pacific is expected to grow with a significant CAGR in the forecast period (2024-2024) because of the rising incidences of chronic diseases including diabetes, infectious diseases, and cancer in the Asia-Pacific countries. According to the OECD 2022, 227 million people have type 2 diabetes in the Asia-Pacific region, among them 50% remain untreated and ignorant about having long-term complications. In addition, the awareness of health among the people in the region has grown, and so has the health care expenditure which has inclined the demand for sophisticated medical devices such as prefilled syringes.

Unlock The Insights of This Strategic Report- https://univdatos.com/report/polymer-based-prefilled-syringe-market/get-a-free-sample-form.php?product_id=61521

Conclusion

Consequently, prefilled polymer syringes are a breakthrough in the polymer technology of drug delivery systems having the following advantages over glass syringes. Their safety, convenience, and relatively cheaper price make the device an attractive tool for pharma and healthcare providers as they seek better ways of attending to patients and cutting costs. With the increasing trend in technology later in the future, the features of polymer-based prefilled syringes can be developed to enhance the growth and use in the healthcare system.

Key Offerings of the Report

Market Size, Trends, & Forecast by Revenue | 2024−2032.

Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities

Market Segmentation – A detailed analysis by polymer type, by application, by end-user, by Region/Country

Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Author: Shalini Bharti

For more details

Contact:

UnivDatos Market Insights

C80B, Sector-8, Noida,

Uttar Pradesh 201301

For Sales related queries, please reach us at sales@univdatos.com

Contact:

UnivDatos Market Insights

contact@univdatos.com 

+91 7838604911

[wellnessweb]

Current Trends Shaping the Cystic Fibrosis Market Size

The Cystic Fibrosis Market size was valued at US$ 6.02 Billion in 2023 and is estimated to reach US$ 16.46 Billion by 2031 with a growing CAGR of 13.4% Over the Forecast Period 2024-2031.The Cystic Fibrosis (CF) market continues to evolve with advancements in treatment options and research aimed at improving the quality of life for patients. As pharmaceutical companies invest in innovative therapies, the landscape of CF care expands, offering hope and possibilities previously unimaginable. The market's growth is driven by a deepening understanding of the genetic and molecular mechanisms underlying CF, paving the way for personalized medicines tailored to specific mutations. This approach not only targets the root cause of the disease but also aims to mitigate its symptoms and complications more effectively than ever before.

Furthermore, the advent of gene therapy holds promise for transformative treatments that could potentially correct the genetic defects responsible for CF, marking a significant leap forward in therapeutic possibilities. Beyond pharmaceutical interventions, supportive therapies and devices designed to enhance respiratory function and manage symptoms play a crucial role in comprehensive CF care. Moreover, initiatives aimed at early diagnosis and proactive management are gaining traction, underscoring the importance of timely intervention in improving outcomes and prolonging life expectancy for individuals with CF. As research continues to unlock new insights and innovations, the CF market stands poised at the forefront of medical progress, driven by a commitment to enhancing the lives of patients and their families worldwide.

Get Sample Of This Report @ https://www.snsinsider.com/sample-request/3442

The research study explores the supply chain from the viewpoint of the industry. It starts with an introduction to the process chart and then on to evaluations of the upstream distributors, downstream consumers, and the costs of the key raw materials. This report includes estimates and predictions for both the worldwide and regional markets, as well as key trends in product development, a typical downstream segment situation, and market drivers and inhibitors. Gross margin, sales, revenue, production, market share, CAGR, and market size by region are all examined. The global Cystic Fibrosis Market's North American, European, Asia-Pacific, Latin American, and the Middle Eastern and African segments.

Key producers, output and production value forecasts by type, and information on forecasting production and production value are all covered in the research report. This study looks at expected price changes as well as supply and demand dynamics in the present global Cystic Fibrosis Market. Along with their revenue, market share, profit margin, core product portfolio, and SWOT analysis, the top companies on the planet are discussed.

Market Segmentation

By Treatment Method

Medication

Devices

By Drug Class

Pancreatic Enzyme Supplements

Mucolytic

Bronchodilators

Antibiotics

CFTR modulators

By Route of Administration

Oral

Inhaled

Research Methodology

The revenue and market share of the leading competitors were obtained as part of the research method used to evaluate and forecast this market. For this comprehensive commercial research of the Cystic Fibrosis Market, secondary sources like press releases, annual reports, non-profit organizations, industry groups, governmental agencies, and customs data were used to find and collect information. These figures were used to estimate the size of the market overall.

Covid-19 Impact Analysis

In this Cystic Fibrosis Market research, the impacts of COVID-19 on the upstream, midstream, and downstream industries are examined. Additionally, this report offers a thorough analysis of the market by highlighting information on a variety of subjects, such as market dynamics, challenges, opportunities, threats, and news and trends in the industry. Finally, this research report offers a comprehensive analysis and knowledgeable advice for handling the time following COIVD-19.

Regional Analysis

A thorough market analysis and advice from industry experts were used to compile the global market study. The global Cystic Fibrosis Market research report covers applications, definitions, manufacturing technologies, as well as a global and regional market overview. A thorough statistical analysis and in-depth assessment of the market from a global perspective, accounting for profit, cost, demand, and supply, are also included in the research report.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Hyperphosphatemia Treatment Market Trends

Hypoparathyroidism Treatment Market Trends

Image guided Biopsy Market Trends

Immunohistochemistry Market Trends

Immunology Market Trends

[industryforecastnews]

Ophthalmic Devices Market Size To Reach $9.79 Billion By 2030 | CAGR of 4.92%

Ophthalmic Devices Market Growth & Trends

The global ophthalmic devices market size is anticipated to reach USD 9.79 billion by 2030, registering a CAGR of 4.92% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising geriatric population is presumed to propel the need for ophthalmic devices due to the high risk of developing chronic eye disorders. According to the National Institute on Aging (NIA), the geriatric population will be about 72 million individuals by 2030. The rising prevalence of eye disorders, such as macular degeneration, cataracts, diabetic retinopathy, and glaucoma, is also boosting product demand. As per the WHO, glaucoma accounts for 4.5 million cases of blindness globally. In the United States, glaucoma is termed the "Silent Thief of Sight," which is the second-leading cause of blindness.

The market growth can also be attributed to technological advancements, such as the development of intraocular lenses, fundus cameras, and OCT devices. Furthermore, the increasing involvement of market players in expanding treatment solutions through strategic alliances is expected to present this market with a potential growth platform. Approximately 10% of the people suffering from eye disorders are expected to experience loss of vision despite the proper treatment, as per the statistics of the WHO, driving the clinical urgency to incorporate highly advanced ophthalmic devices. Furthermore, rising demand for minimally invasive and complication-free operative surgeries is expected to boost product demand. Due to the COVID-19 pandemic, the majority of the population's screen time was increased, resulting in increased cases of various eye issues, which will support market growth over the forecast period.

The growing geriatric population is increasing the demand for ophthalmic devices, as they are more susceptible to age-related ophthalmic disorders. According to the National Institute on Aging (NIA), the geriatric population is expected to reach around 72 million by 2030. The increasing prevalence of diabetes and the incidence of diabetes-related blindness are predicted to fuel market growth. According to the World Health Organization, nearly 422 million people worldwide have diabetes, and the majority are living in low- and middle-income countries.

Increased screen time due to the lockdown measures in the COVID-19 pandemic has been associated with the onset and progression of various eye diseases, thus driving the demand for eye examinations. In June 2020, Johnson & Johnson Vision donated USD 320,000 to provide eye care to COVID-19-impacted patients. The organization conducted this donation to the Optometry Cares unit of the American Optometric Association (AOA) Foundation and the American Academy of Optometry Foundation (AAOF).

Request a free sample copy or view report summary: Ophthalmic Devices Market Report

Ophthalmic Devices Market Report Highlights

Based on product, the optical coherence tomography scanners (OCT) segment dominated the global market in 2023

The segment accounted for the largest share of over 23% of the overall revenue in 2023, which can be attributed to its wide range of applications

The ophthalmoscopes segment is expected to witness significant growth from 2024 to 2030 on account of technological advancements

The cataract application segment accounted for the largest revenue share in 2023 and is expected to continue its dominance over the forecast period

This growth can be attributed to the increasing number of patients suffering from cataracts and high product adoption for cataract surgeries

Regional Insights

North America held the largest share in 2023. A high population of older adults and rising prevalence of chronic eye conditions resulting from factors, such as high stress and unhealthy lifestyles; ultimately leading to diabetic retinopathy, are considered high-impact rendering drivers for the market. In addition, the incorporation of new reimbursement models for ophthalmologic treatment and a stringent regulatory framework aimed at patients’ safety, is expected to fuel product demand in this region.

The U.S. possesses a well-developed healthcare system with leading academic institutions and research facilities. This encourages innovations in ophthalmic devices in terms of minimally invasive surgical techniques, advanced diagnostic instruments, and personalized medicine approaches, thereby propelling growth for the U.S. market. The U.S. spends significantly on healthcare compared to other developed countries, with total healthcare spending projected to reach $4.8 trillion by 2030. This translates into increased funding for specialized therapies and devices, including eye care.

Ophthalmic Devices Market Segmentation

Grand View Research has segmented the global ophthalmic devices market based on product, application, end-use, and region:

Ophthalmic Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

Optical Coherence Tomography Scanners

Fundus Cameras

Perimeters/Visual Field Analysers

Autorefractors and Keratometers

Ophthalmic Ultrasound Imaging Systems

Ophthalmic A-Scan Ultrasound

Ophthalmic B-Scan Ultrasound

Ophthalmic Ultrasound Biomicroscopes

Ophthalmic Pachymeters

Tonometers

Slit Lamps

Phoropters

Wavefront Aberrometers

Optical Biometry Systems

Ophthalmoscopes

Lensmeters

Corneal Topography Systems

Specular Microscopes

Retinoscopes

Ophthalmic Devices Application Outlook (Revenue, USD Million, 2018 - 2030)

Cataract

Vitreo Retinal Disorders

Glaucoma

Refractor Disorders

Ophthalmic Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)

Hospitals & Eye Clinics

Academic & Research Laboratory

Others

Ophthalmic Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

U.K.

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

Latin America

Brazil

Mexico

Argentina

Colombia

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players in Ophthalmic Devices Market

Johnson & Johnson Vision Care

Alcon Vision LLC

Carl Zeiss Meditec AG

Bausch & Lomb Inc.

Essilor International S.A.

Ziemer Ophthalmic Systems Ltd.

Nidek Co. Ltd.

TOPCON Corporation

Haag-Streit Group

Browse Full Report: Ophthalmic Devices Market Report

[omkarpatel]

Ophthalmoscopes Market is Estimated to Witness High Growth Owing to Opportunity for Improved Eye Care

Ophthalmoscopes are medical devices used for examining the interior parts of the eye, primarily the retina. Advancements in ophthalmoscope technology now allow for non-contact or remote examinations which provide clearer views of the retina while reducing patient discomfort.  The global Ophthalmoscopes Market is estimated to be valued at US$ 246.4 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Opportunity: The growing geriatric population is one of the key opportunities driving the ophthalmoscopes market. Older individuals are more prone to developing eye disorders like glaucoma, cataracts and age-related macular degeneration due to biological aging which increases the demand for regular eye checkups and examinations. According to the United Nations, the number of people aged 65 years and above is projected to outnumber children under age 5 by 2030. By 2050, one in six people in the world will be over age 65. The rapid rise in the elderly population base will significantly elevate the need for ophthalmoscopes for improved eye care and diagnosis of age-related eye conditions. This growing demand from the aging demographic is expected to propel the ophthalmoscopes market forward over the forecast period. Porter's Analysis Threat of new entrants: The ophthalmoscopes market requires high R&D investment to develop technologically advanced products. Established brands have strong brand loyalty which poses challenges for new entrants. Bargaining power of buyers: The bargaining power of buyers is moderate as ophthalmoscopes have differentiated products and offerings from different manufacturers. However, price sensitivity is low due to medical necessity. Bargaining power of suppliers: A few manufacturers dominate the supply of key components used in ophthalmoscopes. This concentrates supplier power. Threat of new substitutes: There exist few product substitutes for ophthalmoscopes currently. However, digital technologies may bring alternative diagnosis methods in future. Competitive rivalry: The ophthalmoscopes market sees intense competition among major players. Players differentiate through new features, portability, and expanded product lines. SWOT Analysis Strengths: Growing patient pool for ocular diseases, increasing preference for non-invasive diagnostic methods. Weaknesses: High costs associated, lack of infrastructure and skilled professionals in developing regions. Opportunities: Untapped growth potential in rural areas, rising healthcare budgets, and technological advancements. Threats: Stringent regulatory approvals, reimbursement issues, and threat from refurbished and cheaper products. Key Takeaways The global ophthalmoscopes market is expected to witness high growth over the forecast period driven by aging demographics and rising incidences of ocular disorders. The North American region currently dominates the ophthalmoscopes market owing to increasing healthcare spending and technological advancements. However, Asia Pacific is expected to be the fastest growing market fueled by growing medical tourism, efforts to increase healthcare access and expanding patient pool. Key players operating in the ophthalmoscopes market are Custom Ultrasonics, Inc., EndoMed Systems GmbH., Fujifilm Holdings Corporation, PENTAX Medical Company, Ambu A/S, Medline Industries, Inc., Heine USA Ltd., US Ophthalmic, Welch Allyn, Hill-Rom Holdings Inc (Hillrom), Dino-Lite Europe, HONSUN Group, Rudolf Riester GmbH, IRIDEX Corporation, Zumax Medical Co., Ltd., Oscar Boscarol S.r.l., Suzhou Kangjie Medical Inc., NIDEK Inc., and KIRCHNER & WILHELM GmbH Co. KG. Major players are focusing on product launches and partnerships to strengthen their global presence.

[meghanester]

Syringes and Needles Market Growth with a CAGR of 8.18% During 2023-2035 and Attain USD 68,788.1 Million by 2035

Research Nester’s recent market research analysis on “Syringes and Needles Market: Global Demand Analysis & Opportunity Outlook 2035” delivers a detailed competitor’s analysis and a detailed overview of the global syringes and needles market in terms of segmentation by product, usability, patient group, type, application, end-user, and by region

Increased Number of surgical procedures to Drive Growth of the Global Syringes and Needles Market

The growing utilization of syringes and needles in surgical procedures and the increase in the number of surgical procedures are driving market expansion in the region. The significance of minimally invasive surgery (MIS) is growing in Latin American hospitals. Approximately 80% of elective surgeries are currently performed using this technique. The technique consists of conducting minimal incisions, or even none at all by utilizing natural orifices, through which an endoscope, which is a thin, tube-like device equipped with a video camera as well as a light source, is introduced, allowing the surgeon to visually examine cavities within the body. The increasing number of surgical procedures increases the demand for syringes and needles used in these operations, thereby fostering market expansion.

Get a Sample PDF Brochure: https://www.researchnester.com/sample-request-4983

- The worldwide geriatric population continues to grow at an unprecedented rate, increasing demand for injectable medicines. At the moment, 8.5% of the global population (617 million) is 65 or older. The global population of oldest old people aged 80 and older is expected to more than quadruple between 2015 and 2050, from 126.5 million to 446.6 million.

Some of the major growth factors and challenges that are associated with the growth of the global syringes and needles market are:

Growth Drivers:

Rising Preference for Disposable Products for Blood Collection

Rising Public Awareness of Blood Donation.

Challenges:

NSIs can expose workers to blood-borne and infectious diseases. Injury and infection can cause major distress for workers, as well as significant expenditures for healthcare organizations, and can interrupt the patient treatment process. Therefore, there is an increasing risk of needle-stuck injuries is a major constraint in the market’s growth.

By product, the global syringes and needles market is segmented into syringes and needles where syringes are sub-segmented by general purpose syringes and specialized syringes and needles are sub-segmented by conventional needles and safety needles. By the end of 2035, the syringe segment is anticipated to garner the largest revenue with a CAGR of 8.4 percent. In order to decrease the spread of infections among patients, governments in emerging nations are taking steps to expand the usage of disposable syringes.

Request for customization @ https://www.researchnester.com/customized-reports-4983

By region, the North American syringes and needles market is to generate the highest revenue of USD 22,906.5 Million by the end of 2035. Large businesses in North America have a comparatively high adoption and will likely dominate the syringes and needles market owing to variables such as the growing number of cardiac disorders, along with the surging use of injectable drugs in the region. Increased availability of cutting-edge and proactive medical care and insurance coverage in North America has widened the market for syringes and needles. To maintain their positions in the fiercely competitive market, businesses in the area are investing a lot of money in order to manufacture new products in the Countries such as USA, and China.

Obtain this Report @ https://www.researchnester.com/reports/syringes-and-needles-market/4983

This report also provides the existing competitive scenario of some of the key players of the global syringes and needles market which includes company profiling of Cardinal Health, Inc., Becton, Dickinson, and Company, Allison Medical, Inc., B. Braun SE, Argon Medical Devices, Smiths Medical (ICU Medical, Inc.), Teleflex Incorporated, Apexmed International B.V., EXELINT International, Co., Hindustan Syringes & Medical Devices Ltd., Terumo Medical Corporation, NIPRO Corporation, Misawa Medical Industry Co., Ltd., and other major players.

About Us

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives to take wise decisions for their future marketing strategy, expansion, investment, etc. We believe every business can expand to its new horizon, provided the right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decisions in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

[researchinhealthcare]

Hematuria Treatment Market 2021-2027 High Key Players For Market, Application, Product Sort, Statement

Hematuria Treatment Market Overview :

The hematuria treatment market is accruing rapidly mainly due to the increasing number of bladder or kidney stones; kidney disease; urinary tract infection, cystitis (bladder infection), or pyelonephritis (kidney infection); cancers of the urinary tract (kidney, bladder, prostate); trauma, injury, or urinary tract instrumentation; rigorous exercise; benign prostatic hyperplasia; and blood thinners for such as Antithrombotic medications.

In addition to the chronic diseases, infection or diseases are too impacting the market growth positively. At the same time, there are various treatments and novel medications available for hematuria management which are pushing up the market on the global platform.

Acknowledging the colossal growth, the market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the global hematuria treatment market will grow exponentially by 2023 accruing at a striking CAGR during the forecast period (2018 – 2023).

Furthermore, technological advancements transpired in the field of hematuria management and advent treatment materials are fostering the market growth of hematuria treatment to an extent.

On the other hand, factors such as the complications in the treatment, high cost of product developments, and stringent regulations for approvals are expected to obstruct the market growth during the assessment period. Also, the pending or imminent patent expiries of many blockbuster hematuria management drugs are some hampering the market growth.

Nevertheless, factors like the instigation of a large number of regulatory healthcare reforms, developments of methods for the improved diagnosis and treatments for hematuria are expected to support the market growth bringing about the hematuria management therapeutics and treading along a promising increase in the next few years.

Hematuria Treatment Market – Segments :

The MRFR analysis is segmented into five key dynamics for the convenience of understanding;

By Type : Gross/ Macroscopic Hematuria, Microscopic Hematuria, Idiopathic Hematuria, and Jogger’s Hematuria.

By Causes : Kidney Stones, Urinary Tract Infections (UTI), Urethritis, Blood Cancer, Bladder Stones, Prostate Cancer, Cystitis, Trauma, Vigorous Exercise, Polycystic Kidney Disease, Endometriosis, and Menstruation.

By Treatment : Drugs and Therapeutics, among others.

By End-user : Hospitals, Clinics, and Labs among others.

By Regions : North America, Europe, APAC, and the Rest-of-the-World.

Get Free Sample of This Report at : https://www.marketresearchfuture.com/sample_request/1732

Hematuria Treatment Market – Regional Analysis :

The North American region dominates the global hematuria treatments market. The growing prevalence of kidney diseases, bladder cancer, and others along with the high per capita healthcare expenses drive the growth in the regional market.

Some of the factors such as the increasing technological innovations in medical science and the growing investments into R&D to develop new techniques to treat hematuria are substantiating market growth.

Besides the high consumption of antibiotics in the treatment of various chronic diseases, the presence of a well-established healthcare system, and rising cases of trauma & accidents foster the growth of the hematuria management market in the region.

Europe hematuria treatment market stands at the second position in terms of the size. The market in this region exhibits a phenomenal growth prospect throughout the review period.

Furthermore, factors like financial support from the government for R&D activities, and the increasing demand for hematuria treatments & devices drive the market growth in the region. Besides, the rising incidences of accidental injuries are contributing to the market growth in this region, generating a massive demand for the management of hematuria.

The Asia Pacific hematuria treatment market is emerging as a profitable market.  Factors such as the increasing healthcare expenditure and increasing prevalence of hematuria led by the growing incidences of infections related to the urinary tract, bladder, and kidney drive the growth of the hematuria treatment market in the region.

The increasing governmental funding alongside a large unmet needs presages towards the growth opportunities for the market players. Spreading awareness about the availability of different hematuria management procedures is accelerating the market growth in the region.  Besides, the availability of low-cost, quality hematuria management methods drives the regional market.

Hematuria Treatment Market – Competitive Analysis :

The highly competitive hematuria treatment market appears fragmented owing to a number of players and the increasing investments made by them in R&D activities in the hematuria management. Through the strategic partnership, acquisition, expansion, product & technology launch, and collaboration, these players try to gain a competitive edge.

Hematuria Treatment Market Key Players :

Some of the leaders of the market include Bristol-Myers Squibb, AstraZeneca Plc., F. Hoffmann-La Roche Ltd., Janssen Pharmaceuticals, Inc., GlaxoSmithKline Inc., Merck & Co., Sun Pharmaceutical Industries Limited, Novartis International AG, Pfizer, Inc., and The Medicines Company among others.

Industry/Innovation/Related News :

January 22, 2018 – Researchers at the Sunnybrook Health Sciences Centre’s Division of Urology (Canada) published the result of their study to investigate or manage hematuria in the Journal of the American Medical Association. Researchers examined the rate of hematuria-related complications in over 800,000 elderly patients. And, found that Antithrombotic medications, commonly known as blood thinners are associated with significant adverse events such as blood in the urine (hematuria) or the bleeding within the skull and stomach/ intestines as these drugs allow blood to flow easier throughout the cardiovascular system.

Browse Full Report with TOC at : https://www.marketresearchfuture.com/reports/hematuria-treatment-market-1732

[optimainsights-post]

Urinary Stones Treatment Devices Market to Grow at 4.4% CAGR to Reach US$1.98 billion by 2026

The Global Urinary Stones Treatment Devices Market was valued at US$1.48 billion in the year 2018 and is expected to reach US$1.98 billion by 2026, at a CAGR of 4.4%.

 Urinary stones are mainly formed due to the inability of an individual to empty the urinary bladder. Due to urine accumulation, the minerals in the concentrated urine start crystalizing leading to the formation of stones. Depending on the location of the stone development it may be classified as a kidney stone, bladder stone or ureteral stone. These stones are diagnosed using, abdominal X-ray, CT scan, MRI scan, ultrasound, etc. During the early days, the stones were removed through surgical procedures. But the development of technologies such as lithotripsy, ureteroscopy, nephrolithotomy had reduced the hurdles in treatment and the removal of urinary stones. Also growing popularity of digital flexible ureteroscopes and rising focus on the development of lasers alternative to conventional once are the factors that contribute to the market growth.

Urolithiasis and Nephrolithiasis are the main conditions that contribute to the development of kidney stones in individuals and chiefly contribute to market growth. Besides, the recurrence of kidney stones in the adult population has also risen to 50% in recent decades due to enormous changes in the lifestyle, poor dietary habits, an increase in obesity, less intake of water and many other associated morbidities. Moreover, as recent research suggested, the probability of recurrence of nephrolithiasis in adolescents or children is about 50% within 3 years of the first occurrence. According to the National Kidney Foundation, over half a million people across the globe visit emergency rooms every year. International Federation of Kidney Foundations and the International Society of Nephrology are taking several initiatives to create awareness among the people regarding the equitable and inexpensive access to treatment options, screening, and diagnosis. This is set to drive the Urinary Treatment Devices market during the forecast period.

Implementation of imaging technologies for scanning urinary stones is expected to drive the growth in the upcoming years. Among diagnoses, the ultrasound segment emphasizes reducing the amount of ionizing radiation delivered to patients during routine imaging. It has also become a mainstay tool in the urologists' armamentarium for the diagnosis and management of nephrolithiasis. New advancements in ultrasound technology had also facilitated its use as a therapeutic and therapy guidance aid. Ultrasound is being used as the first line for the diagnosis of urinary stones for more than 14 years and is set to grow with a healthy CAGR of 5.1% during the forecast period. Other diagnostic techniques such as MRI, intravenous pyelogram, non-contrast CT are said to contribute very little when compared to ultrasound.

 Adoption of an alternative way of treatment such as Chinese herbal medicine, Ayurveda, acupressure was minimal during the yesteryears. However, after the rediscovery of the ancient techniques, the options for treating urinary stones with herbal medicine, acupressure, etc. are being researched more and few options have also become successful in minimizing the urinary stones. This is set to hamper the market growth as WHO had already initiated a global level initiative to study and standardize the usage of medicinal plants including that of the folklore medicine.

 However modern medicine offers an effective way of treatment. Among them, the lithotripsy segment has a huge demand in the market treating urinary stones and also to sidestep the invasive surgical procedures that were used for stone removal. Lithotripsy uses ultrasonic energy or shock waves focused directly on the stone to identify the place which was previously located with fluoroscopy or ultrasound of the stones. The patient is positioned in such a way so that the stones are targeted precisely. By using this lithotripsy, the complications, hospital stays, costs and recovery time are reduced. The treatment using lithotripsy is expected to fuel market growth until 2026.

 Among stone types, the calcium oxalate segment has been reported to propel the urinary stones market till 2018. The formation of calcium oxalate stones is strongly linked to the consumption of foods consisting high amount of oxalate that naturally occurs in plants and animals. This includes beets, black tea, chocolate, nuts, potatoes, and spinach. Also, calcium in the form of supplements for several other bone-related disorders may increase the chances of forming new calcium oxalate stones in the urine. Also, consumption of more leguminous foods such as dried beans, peas, anchovies and drinking of beer may increase the chances of uric acid crystal formation due to the deposition of purines in the kidney.

 North American region highly dominates the urinary stones treatment devices market due to extensive prevalence in the occurrence of urinary stones. The favorable conditions for research and development, increased healthcare expenditure and growing utilization of advanced technology for the treatment aspects are evident in this region. The US market holds a market share of about 65% to 35% whereas the Canadian market share is set to increase by around 2% during the forthcoming years due to more immigration from other countries. Further, government initiatives towards strengthening the healthcare infrastructure are accelerating the growth of the urinary stone treatment devices market in this region. Followed by the North American region is the European region, where Germany alone contributes to more than 27% of the total European market growth due to more occurrence of Urolithiasis among German individuals followed by France, the UK, Italy, and Spain. Besides, the Asia Pacific and the Middle East countries are also expected to contribute to the market growth having potential opportunities falling under the kidney stone belt of the world.

 Some of the key players in the urinary stones treatment devices market are, Becton, Dickinson and Company, Boston Scientific Corporation, EDAP TMS S.A., Olympus Corporation, Coloplast A/S, Siemens Healthineers, Convergent Laser Technologies, Cook Medical Inc, Direx Group, Dornier MedTech GmbH, Elmed Electronics & Medical Industry & Trade Inc, KARL STORZ GmbH & Co. KG, Lumenis Ltd, Medispec LTD, Richard Wolf Medical Instruments Corporation, Allengers Medical Systems Ltd and E.M.S. Electro Medical Systems SA.

 Request for Sample Pages @ https://www.optimainsights.org/sample-request/145-urinary-stones-treatment-devices-market

Key Updates:

FDA Approves Retrophin’s New Formula Thiola EC (tiopronin) for treating Cystine Kidney Stones

Dornier’s new Gemini stone-busting system:  The pulverizer is both a step into the future and a blast from the past

Dornier launches AXIS™ Single-Use Digital Ureteroscope for treating Urinary Stones

Journal Summaries in Internal Medicine: Researchers examined the utility of experimental Thulium fiber laser (TFL) as an alternative to the gold standard Holmium: YAG laser for lithotripsy

The Report Provides Key Insights on

History of the Urinary Stones Treatment Devices Market, 2015 to 2017

Forecast of the Urinary Stones Treatment Devices Market Growth till the year 2026

The key market drivers, restraints, challenges, future opportunities and the market dynamics driving the Urinary Stones Treatment Devices Market

Analysis of potential growth segments which will drive the market

Landscape analysis of the major companies, and new market entrants and companies which possess disruptive technologies which can change the trend of the entire market

Key market approaches adopted by the organizations and in-depth intelligence of potential strategies which could alter the market dynamics

Urinary Stones Treatment Devices Market Based on Diagnosis (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)

·         Abdominal X-Ray

·         Computed Tomography(CT) Scan

·         Intravenous Pyelography (IVP)

·         Ultrasound

·         Abdominal MRI

Urinary Stones Treatment Devices Market Based on Treatment (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)

·         Percutaneous Nephrolithotomy (PCNL)

·         Ureteroscopy (URS)

·         Extracorporeal Shock Wave Lithotripsy (ESWL)

Urinary Stones Treatment Devices Market Based on Stone Type (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)

·         Calcium Phosphate

·         Cystine

·         Struvite

·         Uric Acid

·         Calcium Oxalate

Urinary Stones Treatment Devices Market Based on Geographic Region (Market Size and Forecast, and Y-o-Y Growth, (US$ Mn)

·         North America

·         Europe

·         APAC

·         LAMEA

Urinary Stones Treatment Devices Market Competitive Analysis (Company Overview, SWOT Matrix, Financial, Product Overview, and Market Strategies)

·         Siemens Healthineers

·         Direx Systems Corp

·         Dornier Medtech Gmbh

·         Elmed Electronics & Medical Industry & Trade Inc

·         Karl Storz Gmbh & Co. KG

·         Lumenis Ltd

·         Medispec Ltd

·         E.M.S. Electro Medical Systems SA

 Download Complete TOC of the Report @ https://www.optimainsights.org/request-toc/145-urinary-stones-treatment-devices-market

 About Us

Optima Insights is an innovative research and insights-driven enterprise committed to offering actionable intelligence to the global life science and healthcare market. We believe that meaningful insights and improved strategic content hold the key to improved ROI for our clients. We strike an innovative engagement model with our clients to Co-Create Intelligence that would address very specific issues facing them within their functional areas. We continuously support clients through the entire journey map to enable them to make better business decisions towards attaining market leadership.

 Contact

Optima Insights

Mr. Chucks G

+91 966 6620 365 (Asia) | +1 424 2554 365 (US)

Email: Sales@optimainsights.org

https://www.optimainsights.org

[pooja-mahajan]

Dermatoscope Market Growth Analysis, Trends and Scope till 2024

Dermatoscopy is a process through which the examination of skin lesions can be determined using an instrument, i.e., dermatoscope. The instrument is used by dermatologists to distinguish benign tumors and malignant (cancerous) lesions, especially in the diagnosis of melanoma. Modern dermatoscope uses the liquid medium and polarized light in order to cancel out the skin surface reflection.

The images or videos are digitally processed using a digital epiluminescence dermatoscope. 3Gen introduced the first polarized dermatoscope known as DermLite, which allows visualization of skin structures using an immersion fluid. The convenient method of detection and different optimization of images as compared to glass dermatoscope added an advantage over vascular pattern diagnosis. However, new developments in dermatoscope allow image at the cellular and vascular level, paving way for earlier diagnosis and treatment of cancer disease.

Obtain Report Details @ https://www.transparencymarketresearch.com/dermatoscope-market.html

High prevalence of skin cancer disease, rise in patient awareness about skin cancer, growth in research and development initiatives, reduction of the frequency of unnecessary surgical procedures, and high cost of treatment and diagnostic imaging procedures through MRI and X-ray devices are important driving factors of the dermatoscope market. According to the American Academy of Dermatology 2017, the World Health Organization has estimated that more than 65,000 people worldwide are likely to die of melanoma.

In 2017, 9,730 deaths due to melanoma are estimated in the U.S. According to the WHO, 2015, the number of new cases of cancer is expected to rise by about 70% over the next two decades. Growth in technologies such as USB imaging and video technology of imaging melanoma is likely to fuel the growth of the global dermatoscope market. However, introduction of biological agents for melanoma detection and new technologies such as SPECT and PET are expected to hamper the market growth.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20945

The global dermatoscope market has been segmented based on product, technology, modality, application, and geography. In terms of product, the dermatoscope market is classified into contact dermatoscope, hybrid dermatoscope, and non-contact dermatoscope. Polarized dermatoscope (non-contact dermatoscope) is a rapid growing product segment owing to increase in prevalence of skin cancer diseases globally. In terms of technology, the market is classified into LED, xenon, halogen, and ultraviolet. In terms of modality, the market of dermatoscope is classified into hand-handled, trolley mounted, and headband.

According to the Skin Cancer Foundation 2017, more than 419,000 cases of skin cancer are projected to be reported in the U.S. each year, out of which are likely to be 168,000 squamous cell carcinomas, 245,000 basal cell carcinomas, and 6,200 melanomas; these are linked to indoor tanning. In terms of application, the market is classified into skin tumors, scabies, warts, fungal infections, and others. Based on geography, the market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Geographically, North America dominates the global dermatoscope market due to increase in number of melanoma cases among men owing to tanning and ultraviolet rays. Early-phase diagnosis and treatment of the disease is driving the medical biotechnology market, which in turn is expected to drive the North America dermatoscope market. Europe is the second leading market for dermatoscope as there are favorable government policies regarding health care infrastructure and awareness among population against skin cancer.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=20945

The market in Asia Pacific is expected to grow at a higher rate due to rise in population, changing lifestyle, increase in awareness about skin cancer, and growth in per capita expenditure. In addition, economic growth and rise in medical tourism along with research and cancer laboratories are supporting the health care infrastructure improvement in developing countries such as India, Brazil, and China. Thus, all the above mentioned factors collectively support the growth of the dermatoscope market in Asia Pacific and Latin America.

The major players operating in the global dermatoscope market include FotoFinder Systems GmbH, Optilia Instruments AB, Dino-Lite, 3Gen, Rudolf Riester GmbH, NIDEK CO., LTD., ILLUCO Corporation Ltd., KIRCHNER & WILHELM GmbH + Co. KG, and Canfield Scientific, Inc.

[marketinsightshare]

Vision Disorders Market - Forecast, 2022-2027

Vision Disorders Market Size is estimated to reach $47.4 billion by 2027. Furthermore, it is poised to grow at a CAGR of 7.1% over the forecast period of 2022-2027. Vision Disorders are defined as any impairment in the normal sense of vision. Myopia, hyperopia, astigmatism, presbyopia, conjunctivitis, cataract, corneal abrasion, entropion, and glaucoma are only a few of the vision diseases that impact the vast majority of the world's population. The majority of vision impairments are caused by poor nutrition, different diseases, severe eye injury, insertion of foreign objects, and advancing age. Despite tremendous advances in preventing and curing visual impairment in many countries over the last two decades, the World Health Organization (WHO) estimates that over 285 million people worldwide are still visually impaired in 2013. According to the WHO, simple eye examinations such as aberrant blinking frequency, pupil size, and eye color can heal 80 percent of visually impaired patients. Clinical and retinal examinations such as corneal topography, keratometry, pachymetry, fluorescein angiography, Indocyanine Green study (ICG) dye test, and other related studies can confirm the diseases. Ignorance and neglect, on the other hand, might result in serious eye issues or irreversible vision loss. In 2004, the Centers for Disease Control and Prevention (CDC) published research estimating that around 14 million Americans over the age of twelve were affected by various vision impairments, eyeglasses, and contact lenses are generally used in eyesight. Silicone hydrogel contact lenses are a type of advanced soft contact lens that allows more oxygen to pass through to the cornea than traditional soft ("hydrogel") contacts.

Vision disorders Market Report Coverage

The report: “Vision Disorders Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Vision Disorders Market.

By Disease Type- Dry Eye, Eye Allergies, Glaucoma, Cataract, Pterygium, Retinopathy, Eye Infection, Retinal Disorders, Uveitis, and Others.

By Product Type- OTC Drugs, and Prescription Drugs.

By Drug Class- Anti-allergy, Anti-inflammatory, Anti-VEGF (Vascular Endothelial Growth Factor), Anti-glaucoma, Antibacterial, and Others.

By Treatment Type- Drugs, Devices, Others.

By Geography- North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), and Rest of the World (the Middle East, and Africa).

Key Takeaways

Geographically, North America held a dominant market share in the year 2021 on account of increasing pharmaceutical industries. Asia-Pacific is expected to offer lucrative growth opportunities to the manufacturers owing to the increasing manufacturing of ophthalmic products in the pharmaceutical industries. The proliferation of ophthalmic products is predicted to augment the market growth during the forecast period of 2022-2027.

The growing number of ophthalmic pharmaceutical companies entering into strategic initiatives coupled with rising awareness regarding gene therapies are estimated to drive the market growth of the Vision Disorders Market. The growing number of patent expiry of blockbuster drugs poses threat to the Vision Disorders Market growth.

A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Vision Disorders Market Report.

Vision Disorders Market: Market Share (%) by region, 2021

For more details on this report - Request for Sample

Vision Disorders Market Segment Analysis – By Disease Type

Vision Disorders Market based on disease type can be further segmented into Dry Eye, Eye Allergies, Glaucoma, Cataract, Pterygium, Retinopathy, Eye Infection, Retinal Disorders, Uveitis, and Others. The Cataract segment held a dominant market share in the year 2021 and is estimated to be the fastest-growing, with a CAGR of 8.1% over the forecast period of 2022-2027. The increasing prevalence of cataracts is consequently increasing the Eye disorders Market. According to WHO, in 2019, In underdeveloped countries, the occurrence of cataracts similarly rises with age, though it begins sooner in life and is more common. Visually significant cataracts, for example, occurred 14 years earlier in an Indian study than in a comparable study in the United States. The age-adjusted prevalence of cataracts in India was three times that of the United States, with 82 percent of Indians aged 75 to 83 years old having visually significant cataracts or aphakia, compared to 46 percent of those aged 75 to 85 years in the United States (senile lens changes associated with a visual acuity of 6/9 or worse, or a history of cataract extraction). Moreover, at the same point, glaucoma prevalence is also increasing. Hence, cataracts and glaucoma are expected to propel the market of eye disorders in the forecast period 2022-2027.

Vision Disorders Market Segment Analysis – By Drug class

Vision Disorders Market based on Drug class can be further segmented into Anti-allergy, Anti-inflammatory, Anti-VEGF (Vascular Endothelial Growth Factor), Anti-glaucoma, Antibacterial, and Others. The Risk Management & Safety Solution segment held a dominant market share in the year 2021 and is estimated to be the fastest-growing, with a CAGR of 8.9% over the forecast period of 2022-2027. Owing to the increasing prevalence of eye diseases especially age-related macular degeneration, and diabetic retinopathy. Anti-VEGF drugs prevent aberrant blood vessels from leaking, developing, and bleeding beneath the retina. The protein vascular endothelial growth factor (VEGF) encourages the formation of new blood vessels. It also renders blood vessels more prone to leakage. Anti-VEGF drugs block the formation of new blood vessels. Anti-VEGF medication has been approved for age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and myopic choroidal neovascularization in the treatment of vascular and exudative diseases of the retina. Lucentis (ranibizumab) and Avastin are the two most extensively utilized medications at the moment (bevacizumab). Both medications are monoclonal antibodies that attach to each of the three types of VEGF, hence expanding the segment growth.

Vision Disorders Market Segmentation Analysis- By Geography

The Vision Disorders Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 31% in the year 2021 as compared to the other counterparts on account of increasing pharmaceutical industries. Furthermore, the presence of prominent competitors in this area, such as Pfizer, Inc., and Alcon, is projected to boost the market growth. For example, Alcon got FDA approval for Pataday Once Daily Relief and Pataday Twice Daily Relief for OTC sale in the United States in February 2020. The Pataday brand is used to treat itching and allergies in the eyes.

However, Asia-Pacific is estimated to be the fastest-growing over the forecast period of 2022-2027 on account of rising healthcare expenditure, and demand for better healthcare facilities. Local businesses are launching strategic endeavors to create and market innovative patient treatment solutions. As a result, market growth is likely to accelerate. Bridge Biotherapeutics, Inc., for example, acquired an early-stage drug candidate for the treatment of a back-eye disorder from Konkuk University (KU) in February 2020. The therapeutic candidate is an inhibitor of a yet-to-be-identified target protein.

Vision Disorders Market Drivers

Pharmaceutical businesses in the ophthalmic field are embarking on strategic efforts that are propelling the market forward

Ophthalmic pharmaceutical firms are pursuing strategic efforts such as collaborations, acquisitions, and partnerships to add new clinical-stage prospects to their product pipelines, which is projected to enhance the market. Rising ophthalmic pharmaceutical business owing to increasing prevalence of eye disorders. According to the World Health Organization, over 2.2 billion individuals will have a vision impairment or blindness in 2021, with at least 1 billion of those having a vision impairment that can be avoided. Those with limited or severe vision impairment due to unresolved refractive error (123.7 million), cataract (65.2 million), glaucoma (6.9 million), corneal opacities (4.2 million), diabetic retinopathy (3 million), and trachoma (2 million), as well as those with imminent vision impairment due to unspecified presbyopia (1.2 billion) (826 million). The growing senior population is exacerbating the prevalence of ocular illnesses, with uncorrected refractive errors and cataracts being the leading causes of vision impairment. The majority of people with vision problems are above the age of 50, enhancing the Vision Disorders Industry.

Rising prevalence of lifestyle changing diseases, especially diabetes is driving the Market for Vision Disorders

According to CDC, in 2021, Diabetic retinopathy (DR) is a common diabetic condition. It is the primary cause of blindness in adults in the United States. Progressive damage of the blood vessels of the retina, the light-sensitive tissue at the back of the eye that is required for good vision, characterizes it. Mild nonproliferative retinopathy (microaneurysms), moderate nonproliferative retinopathy (blockage in some retinal vessels), severe nonproliferative retinopathy (more vessels are blocked, depriving the retina of blood supply, resulting in the formation of new blood vessels), and proliferative retinopathy (growth of new blood vessels) are the four stages of DR (most advanced stage). Both eyes are generally affected by diabetic retinopathy.

Disease management, which includes adequate control of blood sugar, blood pressure, and lipid abnormalities, reduce the risk of DR. Early detection and treatment of DR lessen the risk of vision loss; nevertheless, up to 50% of patients do not have their eyes tested or are detected too late for effective therapy. It is the primary cause of blindness among working-age adults in the United States, ages 20 to 74. Retinopathy and vision-threatening retinopathy impact an estimated 4.1 million and 899,000 Americans, respectively, thereby driving the market growth.

Vision Disorders Market Challenges

The increasing number of blockbuster medicine patents expiring is projected to stifle Market growth of Vision Disorders

Pharmaceutical businesses will lose exclusivity when their patents expire, but medication producers will be granted new chances and difficulties as the generic competition enters the market. The introduction of generic glaucoma eye drops to the market has lowered patient expenses and increased adherence in some patients thereby decreasing the prevalence of glaucoma disorder Market. For instance, Prostaglandin analogs are anticipated to cost patients more than $100 per month on average across the country. When the first generic prostaglandin analog was introduced in 2011, it was projected that patients switching to the generic version would save more than $1,300 per year. 5 A 30-day prescription for generic latanoprost costs between $19 and $30, according to recent data on www.GoodRx.com, where we practice in mid-Missouri, whereas the same prescription for Xalatan (latanoprost ophthalmic solution; Pfizer) costs between $139 and $154. Hence, the increasing number of blockbuster medicine patents expiring is projected to stifle Market growth of Vision Disorders.

Vision Disorders Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Vision Disorders Market. The top 10- Vision Disorders Market companies are-

Croda International Plc

AbbVie Inc

Aerie Pharmaceuticals, Inc.

Novartis AG

AkzoNobel N.V.

F. Hoffmann-La Roche Ltd.

Evonik Industries

PolyOne Corporation

DuPont

Addcomp Holland

Recent developments

In November 2021, Aerie Pharmaceuticals received marketing authorization approval from the European Commission for its Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for the reduction of elevated IOP in adult patients with primary open-angle.

In October 2021, Abbvie Inc. launched a new drug named VUITYTM (pilocarpine HCl ophthalmic solution). Presbyopia, often known as age-related hazy near vision, is treated with VUITYTM (pilocarpine HCl ophthalmic solution) 1.25 percent in adults. VUITY is the first and only FDA-approved eye drop to treat this prevalent and degenerative eye disease, which affects 128 million Americans, or over half of the adult population in the United States.

In September 2021, Novartis acquired Arctos Medical, bolstering its ophthalmology portfolio with a pre-clinical optogenetics-based AAV gene therapy program and Arctos' proprietary technology. Novartis' dedication to finding solutions for individuals with vision loss, as well as the potential of optogenetics as a foundation for successful therapeutics, is shown in this acquisition.